H Schrezenmeier

Summary

Affiliation: Institute of Transfusion Medicine and Immunology
Country: Germany

Publications

  1. ncbi request reprint Standard first-line immunosuppression for acquired severe aplastic anemia in adults
    Hubert Schrezenmeier
    Institute of Transfusion Medicine, University of Ulm and Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden Wurttemberg Hessen and University Hospital Ulm, Ulm, Germany Helmholtzstraße 10, 89081 Ulm
    Curr Drug Targets . 2015
  2. doi request reprint [Aplastic anemia: Current state of diagnosis and treatment]
    H Schrezenmeier
    Institut fur Transfusionsmedizin, Institut fur klinische Transfusionsmedizin und Immungenetik Ulm, DRK Blutspendedienst Baden Württemberg Hessen und Universitätsklinikum Ulm, Helmholtzstr 10, 89081, Ulm, Deutschland
    Internist (Berl) 56:989-99. 2015
  3. pmc Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties
    Gerlinde Schmidtke-Schrezenmeier
    DRK Blood Service Baden Württemberg Hessia, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
    Cytotherapy 13:962-75. 2011
  4. pmc Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls
    Andreas Hillenbrand
    Department of General and Visceral Surgery, University Hospital of Ulm, Albert Einstein Allee 23, 89081, Ulm, Germany
    BMC Cancer 12:545. 2012
  5. doi request reprint Drugs that inhibit complement
    Hubert Schrezenmeier
    German Red Cross Blood Transfusion Service Baden Württemberg Hessia, Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, and University of Ulm, Helmholtzstraße 10, 89081 Ulm, Germany
    Transfus Apher Sci 46:87-92. 2012
  6. pmc Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients
    Andreas Hillenbrand
    Department of General, Visceral, and Transplantation Surgery, University Hospital of Ulm, Steinhoevelstr, Ulm, Germany
    BMC Surg 10:26. 2010
  7. pmc Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells
    Gloria Isabelle Herzog
    Institute of Transfusion Medicine, University of Ulm, Germany
    BMC Res Notes 4:153. 2011
  8. doi request reprint Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
    H Schrezenmeier
    Red Cross Blood Service Baden Württemberg Hessen, Germany
    Vox Sang 99:1-15. 2010
  9. ncbi request reprint Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets
    Hubert Schrezenmeier
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Donor Service Baden Württemberg Hessia, and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
    Transfusion 47:644-52. 2007
  10. doi request reprint Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Hubert Schrezenmeier
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Service Baden Württemberg Hessen, Germany
    Expert Rev Hematol 2:7-16. 2009

Collaborators

  • J Mytilineos
  • G Walther-Wenke
  • E Seifried
  • Volker Rasche
  • Anna Musyanovych
  • Michael Schmidt
  • R Henschler
  • M Fischer
  • K Hirv
  • Ludwika Kreja
  • Peter Ponsaerts
  • Andrea Tautzenberger
  • Anita A Ignatius
  • Andreas Hillenbrand
  • Volker Mailänder
  • Gloria Isabelle Herzog
  • Ramin Lotfi
  • Katharina Landfester
  • Myriam Ricarda Lorenz
  • B Höchsmann
  • Gerlinde Schmidtke-Schrezenmeier
  • Uwe Knippschild
  • Doris Henne-Bruns
  • D Furst
  • Markus Wiesneth
  • Paul Walther
  • Juliane M Wiehe
  • Verena Holzapfel
  • A Moicean
  • P Ljungman
  • A Risitano
  • Markus Templin
  • Pengfei Xu
  • Anna Maria Wolf
  • Nadine Huber
  • Juliane Fassler
  • Karin Tarte
  • Christian Nienhaus
  • Markus Rojewski
  • Denis S Wiegmann
  • Cedric Menard
  • Natalie Fekete
  • Markus Urban
  • Ghasem Solgi
  • Erika Deak
  • Tatjana Yildiz
  • Markus Huber-Lang
  • Anna M Wolf
  • Manfred Weiss
  • G Solgi
  • JAMES JOSEPH LEE
  • Anna Rubartelli
  • Richard Anthony DeMarco
  • Michael Thomas Lotze
  • Donna Beer-Stolz
  • Karin Fuchs
  • Joerg M Homann
  • Markus T Rojewski
  • Desiree Kronawitter
  • Jan Torzewski
  • Vinzenz Hombach
  • Jochen Greiner
  • Oliver Zimmermann
  • Karin Nothelfer
  • Hendrik Frank

Detail Information

Publications19

  1. ncbi request reprint Standard first-line immunosuppression for acquired severe aplastic anemia in adults
    Hubert Schrezenmeier
    Institute of Transfusion Medicine, University of Ulm and Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden Wurttemberg Hessen and University Hospital Ulm, Ulm, Germany Helmholtzstraße 10, 89081 Ulm
    Curr Drug Targets . 2015
    ..Here we will discuss standard treatment, the importance of type of antithymocyte globulin and results of various modifications of the standard regimen including new perspectives...
  2. doi request reprint [Aplastic anemia: Current state of diagnosis and treatment]
    H Schrezenmeier
    Institut fur Transfusionsmedizin, Institut fur klinische Transfusionsmedizin und Immungenetik Ulm, DRK Blutspendedienst Baden Württemberg Hessen und Universitätsklinikum Ulm, Helmholtzstr 10, 89081, Ulm, Deutschland
    Internist (Berl) 56:989-99. 2015
    ..Ongoing trials now address the potential role of eltrombopag as an adjunct to immunosuppression in first-line treatment...
  3. pmc Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties
    Gerlinde Schmidtke-Schrezenmeier
    DRK Blood Service Baden Württemberg Hessia, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
    Cytotherapy 13:962-75. 2011
    ..However, most publications lack a comprehensive assessment of the non-interference of the contrast agent with the functionality of the labeled MSC, which is a prerequisite for the validity of cell-tracking via MRI...
  4. pmc Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls
    Andreas Hillenbrand
    Department of General and Visceral Surgery, University Hospital of Ulm, Albert Einstein Allee 23, 89081, Ulm, Germany
    BMC Cancer 12:545. 2012
    ....
  5. doi request reprint Drugs that inhibit complement
    Hubert Schrezenmeier
    German Red Cross Blood Transfusion Service Baden Württemberg Hessia, Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, and University of Ulm, Helmholtzstraße 10, 89081 Ulm, Germany
    Transfus Apher Sci 46:87-92. 2012
    ..g. cold agglutinin disease; atypical HUS) and new approaches to complement inhibition with drugs other than eculizumab...
  6. pmc Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients
    Andreas Hillenbrand
    Department of General, Visceral, and Transplantation Surgery, University Hospital of Ulm, Steinhoevelstr, Ulm, Germany
    BMC Surg 10:26. 2010
    ..In this study we examined the serum adipocytokine profile in critically ill patients, MO patients, and healthy blood donors...
  7. pmc Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells
    Gloria Isabelle Herzog
    Institute of Transfusion Medicine, University of Ulm, Germany
    BMC Res Notes 4:153. 2011
    ..Nevertheless, the maturation inducing effect of tumor lysates on DCs is discussed controversially and the efficacy of tumor vaccines varies significantly...
  8. doi request reprint Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
    H Schrezenmeier
    Red Cross Blood Service Baden Württemberg Hessen, Germany
    Vox Sang 99:1-15. 2010
    ....
  9. ncbi request reprint Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets
    Hubert Schrezenmeier
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Donor Service Baden Württemberg Hessia, and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
    Transfusion 47:644-52. 2007
    ....
  10. doi request reprint Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Hubert Schrezenmeier
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Service Baden Württemberg Hessen, Germany
    Expert Rev Hematol 2:7-16. 2009
    ..Experience from the pilot study and the Phase III pivotal program of eculizumab in PNH will be summarized and the impact of eculizumab on the future treatment of PNH will be discussed...
  11. doi request reprint The frequency of DRB1*1454 in South German Caucasians
    D Furst
    German Red Cross Blood Donation Service, Baden Wuerttemberg Hessen, Ulm, Germany
    Tissue Antigens 76:57-9. 2010
    ..HLA-DRB1*1454 is the most common DRB1*14 allele among German Caucasians and should be considered as a preferred allele over DRB1*1401...
  12. doi request reprint How much blood is needed?
    E Seifried
    Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden Wuerttemberg Hessen and Clinics of the Johann Wolfgang Goethe University Frankfurt Main, Frankfurt Main, Germany
    Vox Sang 100:10-21. 2011
    ..Different blood donor groups require specific approaches and, for example, inactive or deferred donors must be re-activated. Optimal use of blood components requires even more attention...
  13. doi request reprint Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents
    Volker Mailänder
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Institute of Transfusion Medicine, University of Ulm, Helmholtzstr 10, 89081 Ulm, Germany
    Mol Imaging Biol 10:138-46. 2008
    ..A steady increase in uptake of nanoparticles was detected with a higher density of carboxyl groups showing the relevance of charged groups as in the case of Resovist. Aggregation of these polymeric nanoparticles was not found...
  14. doi request reprint Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies
    K Hirv
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, University of Ulm and German Red Cross Blood Donation Service, Baden Wuerttemberg, Hessen, Germany
    Bone Marrow Transplant 44:433-40. 2009
    ..An unrelated donor can be found for most of the patients, even if the indication for transplantation is urgent...
  15. doi request reprint Supportive care in severe and very severe aplastic anemia
    B Höchsmann
    Institute of Clinical Transfusion Medicine, German Red Cross Blood Transfusion Service, Baden Württemberg Hessia and University of Ulm, Ulm, Germany
    Bone Marrow Transplant 48:168-73. 2013
    ..More controlled studies on supportive care should be performed in this rare disease...
  16. pmc mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression
    Juliane M Wiehe
    Department of Internal Medicine II, University of Ulm, Ulm, Germany
    J Cell Mol Med 11:521-30. 2007
    ..It may be useful to transiently manipulate stem cell characteristics and thus combine principles of gene therapy and tissue engineering...
  17. doi request reprint Effect of functionalised fluorescence-labelled nanoparticles on mesenchymal stem cell differentiation
    Andrea Tautzenberger
    Institute of Orthopaedic Research and Biomechanics, Centre of Musculoskeletal Research, University of Ulm, Helmholtzstrasse 14, 89081 Ulm, Germany
    Biomaterials 31:2064-71. 2010
    ..It was concluded that the surface functionalisation with phosphonate groups provides a promising basis for the development of nanoparticles with high intracellular uptake rates for drug delivery or cell labelling...
  18. doi request reprint Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells
    Ramin Lotfi
    Institut fur klinische Transfusionsmedizin und Immungenetik Ulm, Institut fur Transfusionsmedizin Universitat Ulm, Ulm, Germany
    J Immunol 183:5023-31. 2009
    ..Novel therapeutic strategies may be considered by advancing oxidative denaturation of released necrotic material using Eos or other aerobic strategies...
  19. ncbi request reprint Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells
    Myriam Ricarda Lorenz
    Department of Transfusion Medicine, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, University of Ulm, Helmholtzstr 10, 89081 Ulm, Germany
    Biomaterials 27:2820-8. 2006
    ..Scanning electron microscopy showed microvilli to be involved in this process...